A 67-year-old man with type 2 diabetes (HbA1c 70 mmol/mol) and BMI 34 has eGFR 62 mL/min/1.73 m². He is on metformin. Which agent has proven cardioren...

Question

A 67-year-old man with type 2 diabetes (HbA1c 70 mmol/mol) and BMI 34 has eGFR 62 mL/min/1.73 m². He is on metformin. Which agent has proven cardiorenal benefit and is appropriate to add?

Accepted Answer

Empagliflozin

Answer

Sitagliptin

Answer

Gliclazide

Answer

Acarbose

Answer

Pioglitazone

ukmla MCQ (SBA): Type 2 diabetes therapy

A 67-year-old man with type 2 diabetes (HbA1c 70 mmol/mol) and BMI 34 has eGFR 62 mL/min/1.73 m². He is on metformin. Which agent has proven cardiorenal benefit and is appropriate to add?